×
ACM Global Laboratories Unveils New Testing Services for Oncology Trials at 2018 ASCO Annual Meeting
Global Central Lab Extends Smarter Testing™ to Deliver Tailored Clinical Trials Testing and Expertise to Sponsors and CROs Involved in Cancer Research
 
ASCO 2018, Chicago, May 31, 2018 – ACM Global Laboratories, an affiliate of Rochester Regional Health and one of the largest independent central labs in the industry specializing in high-quality central laboratory testing, toxicology and diagnostic lab services, today announced a new therapeutic service offering to support the specific testing needs of oncology clinical trials. ACM’s Smarter Testing™ for Oncology brings together key elements to optimize oncology clinical trial outcomes. Beginning with an in-house staff of subspecialty pathologists and access to a growing network of remote pathologists, a continuous commitment to state-of-the-art image analytics and an extensive test menu of immunohistochemical and molecular testing, ACM’s wide range of general and subspecialty services in surgical pathology, cytopathology, and clinical pathology support the precision medicine revolution taking place in oncology research.
 
With demand for pathological services in clinical trials on the rise and anatomic pathologists in increasingly short supply, access to subspecialized pathologists has never been more critical. In response to this increased demand, ACM has developed Smarter Testing for Oncology to deliver a unique service offering for clients conducting cancer research. Smarter Testing for Oncology is an extension of the company’s Smarter Testing consultative approach, which advocates working with sponsors and CROs to identify their endpoints and collaborate to find the optimal laboratory testing for their study.
 
“We have been conducting testing for oncology trials for many years and recognized the power of bringing these individual components together in a complete package for our clients,” said Matthew Turner, MD, Director of Pathology at ACM Global Laboratories. “Oncology trials have some distinct characteristics from other types of trials due to their complexity and need for biomarker analysis and companion diagnostics. Our team is ideally suited to address these trial nuances through our continuous exposure to complicated cancer resections that we see at Rochester Regional Health.”
 
The Smarter Testing for Oncology includes four key elements:
  • Access to scientific experts and subspecialty pathologists. As an affiliate of Rochester Regional Health (RRH), ACM offers access to a staff of more than 20 in-house pathologists, as well as a growing network of subspecialty pathologists and practicing oncologists, who regularly collaborate on study design.
 
  • Extensive oncology test menu. ACM has a comprehensive offering of in-house ancillary testing that includes flow cytometry, in-situ hybridization and immunohistochemistry and maintains strategic relationships with leading reference laboratories to offer the full gamut in cutting-edge oncologic testing, including immunohistochemical and molecular testing.
 
  • Continuous commitment to state-of-the-art image analytics. ACM embraces whole slide imaging technology, which increases its ability to scale pathology resources for sponsors and CROs conducting global oncology trials, and tumor cell detection and biomarker quantification software, which helps provide objective cell counts for quicker turnarounds and more accurate and objective diagnosis.  
 
  • A Smarter Testing approach. Working with its in-house pathologists, ACM’s scientific affairs experts help tailor the testing according to the study endpoints. By determining the classification of the cancer, understanding the variants in the patient, the effectiveness of a drug on a particular tumor and the markers or stains being looked at, ACM ensures the most appropriate and cost-effective tests are chosen for the desired outcome and that critical trial milestones are feasible.
 
For more information on ACM's Smarter Testing for Oncology services or to schedule a meeting at ASCO, visit http://bit.ly/ACM-oncology, stop by Booth #6143 at the conference or connect with us - Twitter, LinkedIn and Facebook.
 
About ACM Global Laboratories
ACM Global Laboratories, an affiliate of Rochester Regional Health, is one of the largest global independent central labs in the industry. ACM is CAP and SAMHSA certified. The company delivers high-quality laboratory testing and diagnostic lab services in support of both clinical trials research, toxicology and individual patient care. ACM provides a powerful combination of operational excellence, scientific expertise, and unsurpassed global service to customers in more than 65 countries. ACM performs more than 30 million laboratory tests each year—spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology, and more. For more information, visit www.acmgloballab.com or call +1 866 405 0400.
 
About Rochester Regional Health
Rochester Regional Health is an integrated health services organization serving the people of Western New York, the Finger Lakes and beyond. The system includes five hospitals; primary and specialty practices, rehabilitation centers, ambulatory campuses and immediate care facilities; innovative senior services, facilities and independent housing; a wide range of behavioral health services; and Rochester Regional Health Laboratories and ACM Global Laboratories, a global leader in patient and clinical trials. Rochester Regional Health is the region’s second largest employer. Learn more at RochesterRegional.org.

 
 
 

email us at: info@acmgloballab.com
© ACM Global Laboratories 2017.
All rights reserved

HIPAA Privacy Statement